What is Cullinan Therapeutics, Inc.'s total revenue?

Cullinan Therapeutics, Inc. (CGEM) reported total revenue of $0 in Q4 2022.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Cullinan Therapeutics, Inc. CGEM Total Revenue

Discontinued — last reported Q4 '22

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

Johnson & JohnsonJNJ

$24.06B+9.9%

AmgenAMGN

$8.62B+5.8%

Regeneron PharmaceuticalsREGN

$3.61B+19.0%

Janux TherapeuticsJANX

$3.73M—

Nektar TherapeuticsNKTR

$10.86M+3.8%

Other financials

Income statement

See full

Operating income-$53.7M+2.4%

Net income-$49.7M-2.4%

EPS (diluted)-$0.69+24.2%

Balance sheet

See full

Cash & equivalents$75.1M-2.1%

Total debt$2.4M+29.5%

Total equity$408.7M-30.8%

Total assets$403.0M-30.5%

Cash flow

See full

Operating cash flow-$46.0M-6.7%

CapEx$11.0K—

Free cash flow-$38.1M-4.1%

Valuation

See full

Market cap$1.08B+140%

Enterprise value$1.01B+168%

Profitability

See full

Operating margin-358.7%—

Net margin-346.1%—

Returns & leverage

See full

Return on equity-44%+26.2pp

Debt / equity0×0.0×

Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s total revenue?: Cullinan Therapeutics, Inc. (CGEM) reported total revenue of $0 in Q4 2022.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.